Simulations of surface charge density changes during the untreated solid tumor growth
Authors:
Henry Bory Prevez,
Argenis Adrian Soutelo Jimenez,
Eduardo José Roca Oria,
José Alejandro Heredia Kindelán,
Maraelys Morales González,
Narciso Antonio Villar Goris,
Nibaldo Hernández Mesa,
Victoriano Gustavo Sierra González,
Yenia Infantes Frometa,
Juan Ignacio Montijano Torcal,
Luis Enrique Bergues Cabrales
Abstract:
Understanding the untreated tumor growth kinetics and its intrinsic findings is interesting and intriguing. The aim of this study is to propose an approximate analytical expression that allows to simulate changes in surface charge density changes at cancer-surrounding healthy tissue interface during the untreated solid tumor growth. For this, the Gompertz and Poisson equations are used. Simulation…
▽ More
Understanding the untreated tumor growth kinetics and its intrinsic findings is interesting and intriguing. The aim of this study is to propose an approximate analytical expression that allows to simulate changes in surface charge density changes at cancer-surrounding healthy tissue interface during the untreated solid tumor growth. For this, the Gompertz and Poisson equations are used. Simulations reveal that the unperturbed solid tumor growth is closely related to changes in the surface charge density over time between the tumor and the surrounding healthy tissue. Furthermore, the unperturbed solid tumor growth is governed by temporal changes in this surface charge density. It is concluded that graphic strategies corroborate the correspondence between the electrical and physiological parameters in the untreated cancer, which may have an essential role in its growth, progression, metastasis and protection against immune system attack and anti-cancer therapies. In addition, the knowledge of surface charge density changes at cancer-surrounding healthy tissue interface may be relevant when redesigning the molecules in chemotherapy and immunotherapy taking into account their polarities. This can also be true in the design of completely novel therapies.
△ Less
Submitted 13 September, 2022; v1 submitted 8 February, 2022;
originally announced February 2022.
